Sign in

Dr. William Frazier

Chief Medical Officer at VIEMED HEALTHCARE
Board
Since December 21, 2017
Age
67 years
Education
Holds a Bachelor of Science in Philosophy from Vanderbilt University, an M.D. from the University of Mississippi, and completed post-doctoral training at the University of Virginia.
Tenure
Joined VMD as Chief Medical Officer and Director on December 21, 2017, and has held these roles since then.

About

Dr. William Frazier, currently 67 years old , has achieved a distinguished career in the medical field with a primary focus on pulmonary medicine. Over a span of more than 30 years as a practicing pulmonologist, he has also served in various leadership roles that underscore his expertise in clinical research and patient care.

After a long and impactful clinical career, he transitioned into executive leadership. Serving as Chief Medical Officer and Director at VMD since 12-21-2017 , he has been instrumental in guiding respiratory care programs, enhancing clinical protocols, and ensuring compliance with healthcare standards. His contributions have enabled the company to advance its respiratory disease management initiatives.

His comprehensive educational background, validated by board certifications in Internal Medicine, Pulmonary Medicine, Critical Care Medicine, and Sleep Disorders Medicine , reinforces his commitment to high-quality patient care. This blend of extensive clinical experience and executive leadership marks him as a key asset in advancing VMD's mission, fostering improvements in respiratory health services.

Past Roles

OrganizationRoleDate RangeDetails
PHM Chief Medical Officer October 2015 – December 2017
Sleepco Subsidiaries Chief Medical Officer Started October 2015 (end date not specified) Role held prior to joining PHM
Medical Practices & Health Systems Practicing Pulmonologist & Leadership roles (Chief of the Medical Staff, Board positions) Over 30 years Held leadership roles including Chief of the Medical Staff and board memberships

Fixed Compensation

Data from  FY 2024
Component NameAmountPayment ScheduleAdditional Details
Stock Awards (2020 LTIP)$77,801 Vesting in 3 equal annual installments starting Jan 29, 2025 Includes 7,003 RSUs and 2,334 Phantom Shares
Wages$221,858 2024 Annual Payment Compensation for his role as Chief Medical Officer
Options36,261 options Outstanding as of Dec 31, 2024 Granted in prior years; exercise price and expiration details not provided
Cash Bonus Plan$77,072 Awarded in 2024 under the Cash Bonus Plan Bonus received as part of his overall compensation for the Chief Medical Officer role

Performance Compensation

Data from  FY 2024

No information available on performance compensation for 2024